AUTL Stock Analysis: Buy, Sell, or Hold?
AUTL - Autolus Therapeutics plc American Depositary Share
$1.95
0.13 (7.20%)
▲
5d:
+34.55%
30d:
+19.69%
90d:
+24.27%
WAIT
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Get Alerted When AUTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AUTL is 16.1% above its trading range ($1.68). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AUTL is 16.1% above its trading range ($1.68). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AUTL is currently trading at $1.95, which is considered extended relative to its 30-day fair value range of $1.43 to $1.68.
Technical Outlook: Technically, AUTL is in a uptrend. Immediate support is located at $1.38, while resistance sits at $2.08. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: AUTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.55 (+369.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AUTL is in a uptrend. Immediate support is located at $1.38, while resistance sits at $2.08. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: AUTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.55 (+369.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.43 -
$1.68
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+16.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.2%)
- BULLISH: Trading 369.8% below Wall St target ($8.55)
- WARNING: Recommendation downgraded due to 16.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$1.43 -
$1.68
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.38
Resistance Level
$2.08
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.01
Wall Street Target
$8.55
(+369.8%)
Revenue Growth (YoY)
83655.2%
Share & Embed Analysis
Last updated: August 04, 2026 11:52 AM ET
Data refreshes hourly during market hours. Next update: 12:52 PM
Data refreshes hourly during market hours. Next update: 12:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AUTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$15 | 51 HOLD |
